Latest Reports on Trending Tickers: Starbucks and Colgate-Palmolive Post Earnings

NEW YORK, NY / ACCESSWIRE / January 30, 2017 / A combination of corporate earnings and strong performances by the manufacturers and miners helped U.S. markets post strong weekly gains during President Trump’s first week in office. The Dow Jones Industrial Average declined 0.04 percent to close at 20,093.78, up 1.33 percent for the week, while the S&P 500 Index declined 0.09 percent to close at 2,294.69, up 1.01 percent for the week. The Nasdaq rose 0.10 percent to close at a new record 5,660.78, posting a weekly gain of 1.88 percent.

As of 104 companies in the S&P 500 Index reporting earnings through Wednesday morning approximately 70 percent have topped expectations, according to data from Thomson Reuters I/B/E/S. Earnings in the fourth quarter are forecasted to show a growth of 6.8 percent, which would be the largest growth rate seen in two years.

Starbucks Corporation (NASDAQ: SBUX)

Get Your Up-To-Date Starbucks Research
Report Click Here

Starbucks’ shares declined 4.00 percent to close at $56.12 a share Friday. The stock traded between $55.65 and $56.59 on volume of 28.88 million shares traded. The company reported adjusted earnings of $0.52 per share on revenues of $5.73 billion for the first quarter of fiscal 2017, which compared to the Street’s estimates of adjusted earnings of $0.52 per share and revenues of $5.85 billion. Starbucks reported same-store sales growth of 3 percent for the fiscal first quarter, which fell short of analysts’ estimates of 3.8 percent. The company has attributed some of the drop in same-store sales to mobile pay and ordering.

“We are pleased with the record Q1 financial and operating results we announced today, particularly given that the results were delivered in the face of a challenging environment for restaurant retailers overall,” Scott Maw, CFO of Starbucks said in their earnings release.

Colgate-Palmolive Company (NYSE: CL)

Get Your Up-To-Date Colgate-Palmolive
Research Report Click Here

Colgate-Palmolive’s shares declined 5.22 percent to close at $64.68 a share Friday. The stock traded between $63.43 and $65.05 on volume of 14.87 million shares traded. The company reported a net income of $606 million, or $0.68 per share, for the fourth quarter of 2016, compared to a loss of $458 million, or a loss of $0.51 per share, for the fourth quarter of 2015. Sales totaled $3.72 billion for the fourth quarter, which was a decline from $3.9 billion a year ago and below consensus analysts’ estimates of $3.89 billion, according to FactSet. Organic sales growth at the company was 1.5 percent for the quarter, with a 2.5 percent rise in price and 1 percent decline in volume. Considering current exchange rate, the company expects a low single-digit growth in net sales and per share earnings in the year 2017.

“As we look ahead, uncertainty in global markets and foreign exchange volatility remain challenging, which sees us redoubling our focus on profitable growth. While based on current spot rates, we expect a low-single-digit net sales increase for 2017, we anticipate another year of solid organic sales growth driven by a full new product pipeline, engaging marketing programs and strong advertising support,” commented Ian Cook, Chairman, President and Chief Executive Officer.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 453786

Go Top